Similar articles

• 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.

  Paneni F. Paneni F. Diab Vasc Dis Res. 2014 Jan;11(1):5-10. doi: 10.1177/1479164113512859. Epub 2013 Nov 19. Diab Vasc Dis Res. 2014. PMID: 24254974 No abstract available.
• [Hypertension in diabetes mellitus. Causes, follow-up and treatment].

  Klaus D. Klaus D. Med Klin (Munich). 1994 Jun 15;89(6):330-8. Med Klin (Munich). 1994. PMID: 8072457 Review. German. No abstract available.
• Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.

  Lamanna C, Monami M, Marchionni N, Mannucci E. Lamanna C, et al. Diabetes Obes Metab. 2011 Mar;13(3):221-8. doi: 10.1111/j.1463-1326.2010.01349.x. Diabetes Obes Metab. 2011. PMID: 21205121
• [Update diabetes mellitus and cardiovascular diseases].

  Otter W. Otter W. MMW Fortschr Med. 2012 Apr 19;154(7):95-8. MMW Fortschr Med. 2012. PMID: 22558884 German. No abstract available.
• [Antihypertensive treatment in type II diabetes and diabetic nephropathy].

  Chantrel F, Bouiller M, Kolb I, Hannedouche T. Chantrel F, et al. Nephrologie. 2000;21(2):47-55. Nephrologie. 2000. PMID: 10798204 Review. French.